Funder: Patient-Centered Outcomes Research Institute
Due Dates (Anticipated): May 2026 (Letter of Intent) | September 2026 (Full application)
Funding Amounts: Up to $12 million direct costs per award; max project period 5 years; total funds available up to ~$60 million (anticipated for the cycle).
Summary: Supports comparative clinical effectiveness research to improve health outcomes for people with intellectual and developmental disabilities, with emphasis on oral health, GI health, and care delivery.
Key Information: This is a forecasted opportunity; all dates are projected—refer to the program page for updates.